Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00HQE
|
|||
| Former ID |
DIB002986
|
|||
| Drug Name |
Ty800
|
|||
| Indication | Infectious disease [ICD-11: 1A00-CA43.1; ICD-9: 001-139] | Phase 2 | [1] | |
| Company |
Avant Immunotherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00498654) Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.